(Q37975507)

26 August 2017

Simultaneous surgery for primary colorectal cancer and metastatic lesions? (English)

1 reference

26 August 2017

1 reference

1 reference

Bengt Gustavsson

1

1 reference

26 August 2017

16 January 2012

1 reference

Scandinavian Journal of Gastroenterology

26 August 2017

1 reference

26 August 2017

47

1 reference

26 August 2017

3

1 reference

26 August 2017

269-276

1 reference

26 August 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Role of new agents in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Use of clinical score to stage and predict outcome of hepatic resection of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

The management of resectable and unresectable liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Surgery for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Symptoms and signs in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Surgery combined with oncological treatments in liver metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Colorectal cancer: mutations in a signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Extending limits of resection for metastatic colorectal cancer: risk benefit ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Ablative therapies for colorectal liver metastases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Staged or simultaneous resection of synchronous liver metastases from colorectal cancer--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Role of surgery in colorectal liver metastases: too early or too late?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Cancer of the rectum--palliative endoscopic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Colonic stents: the modern treatment of colonic obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.640824

10.3109/00365521.2012.640824

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22242554